Latest Share Chat

REMOVE ADS

MaxCyte Share News (MXCT)

MaxCyte Information

There is currently no data for MXCT

REMOVE ADS

MaxCyte News

IN BRIEF: MaxCyte first-quarter loss narrows; raises annual guidance

MaxCyte Inc - Gaithersburg, Maryland-based platform for cell-based research - Says is pleased with positive start to 2022 with "very strong" first-qua...

MaxCyte reports good first quarter revenue growth

(Sharecast News) - Cell engineering technology company MaxCyte reported total first quarter revenue of $11.6m (£9.42m) in an update on Tuesday - ...

TRADING UPDATES: BlueRock output rises; Watkin Jones profit to fall

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

MaxCyte CFO resigns, first quarter revenues rise

(Sharecast News) - Cell engineering company MaxCyte announced on Wednesday that Amanda Murphy has resigned from her position as chief financial office...

MaxCyte widens net loss in 2021 while annual revenue increases

(Alliance News) - MaxCyte Inc on Wednesday posted a widened net loss of USD19.1 million in 2021, increased from a loss of USD11.8 million the year bef...

MaxCyte reports record Q4 and full-year revenue

(Sharecast News) - Cell engineering company MaxCyte reported record quarterly revenue of $10.2m (£7.73m) for the final three months of 2021 on We...

UK earnings, trading statements calendar - next 7 days

IN BRIEF: MaxCyte hires chief scientist from Stemson Therapeutics

MaxCyte Inc - Maryland-based platform for cell-based research - Hires Cenk Sumen as chief scientific officer. Sumen joins from San Diego, California-b...